Evidence map›Paper›PMID 32257607›Full record

ArticleInternational journal of MCH and AIDS2019

Epidemiology of Opportunistic Infections in HIV Infected Patients on Treatment in Accredited HIV Treatment Centers in Cameroon.

Ornella Sybile D Kouanfack, Charles Kouanfack, Serges Clotaire Billong, Samuel N Cumber, Claude N Nkfusai, Fala Bede, Emerson Wepngong, Chombong Hubert, Georges Nguefack-Tsague, Madeleine N Singwe

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of MCH and AIDS, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. A Pilot Study of COVID-19 Outcomes in People Living with HIV in Tatarstan.International journal of molecular sciences · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 4 countries.

Ornella Sybile D KouanfackFaculty of Medicine and Biomedical Sciences, University of Yaounde 1, Cameroon.
Charles KouanfackDay Hospital, Yaounde Central Hospital, Cameroon.
Serges Clotaire BillongFaculty of Medicine and Biomedical Sciences, University of Yaounde 1, Cameroon.
Samuel N CumberSchool of Health Systems and Public Health, Faculty of Health Sciences, University of Pretoria Private Bag X323, Gezina, Pretoria, 0001, Pretoria, South Africa.
Claude N NkfusaiDay Hospital, Yaounde Central Hospital, Cameroon.
Fala BedeDay Hospital, Yaounde Central Hospital, Cameroon.
Emerson WepngongDay Hospital, Yaounde Central Hospital, Cameroon.
Chombong HubertDay Hospital, Yaounde Central Hospital, Cameroon.
Georges Nguefack-TsagueFaculty of Medicine and Biomedical Sciences, University of Yaounde 1, Cameroon.
Madeleine N SingweFaculty of Medicine and Biomedical Sciences, University of Yaounde 1, Cameroon.
Central Hospital of Yaoundé · CMUniversité de Yaoundé I · CMCameroon Baptist Convention Health Services · CMUniversity of Gothenburg · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe African continent accounts for over 70% of people infected with Human Immunodeficiency Virus (HIV). The HIV sero-prevalence rate in Africa is estimated at 4.3%. In developed countries, such as France, pneumocystis is indicative of AIDS in 30% of patients; however, in Africa, pulmonary tuberculosis (TB) is the most-documented opportunistic infection (OI) and the leading cause of death in HIV-infected patients. In 2016, Cameroon had 32,000 new cases of OI and 29,000 deaths as a result of these infections. However, there is little existing data on the epidemiological profile of OIs in Cameroon, which is why we conducted this study in accredited HIV treatment centers and care/treatment units in the two cities of Douala and Yaounde, Cameroon.

methodsThis was a retrospective descriptive and analytical study carried out in 12 accredited HIV treatment centers in the cities of Yaoundé and Douala, Cameroon, over a period of seven months from October 2017 to April 2018. A stratified sampling method was used with three sampling levels: the city, type of health facility and size of active files. Ethical clearance and administrative authorization were obtained from the appropriate authorities and data were collected using a pre-tested survey form. The data collected was entered and analyzed using Epi Info version 3.5.4.

resultsOut of a total of 1,617 HIV-infected patients sampled, 419 (25.9%) had at least one OI. Of these patients with an OI, 246 or 65% had a baseline CD4 count of <200/mm CONCLUSION AND GLOBAL HEALTH IMPLICATIONS: The prevalence of OI is high among people living with HIV (25.9%). Shingles was the most common OI found followed by pulmonary tuberculosis. Male gender, age ≥ 50 years, and CD4 <200/mm

Indexed as

AIDS treatment centersATCCameroonHIV/AIDSOpportunistic infectionsShinglesTuberculosisUPEC

Identifiers

PMID32257607
PMCPMC7099574
OpenAlexW3028311538

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.